Obesity and Fatty Liver (MASLD/MASH)

Obesity as a chronic disease, and metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH).

Scope

  • Evaluation and long-term management of obesity
  • Anti-obesity pharmacotherapy and metabolic and bariatric surgery
  • MASLD and MASH: risk stratification, non-invasive fibrosis assessment and treatment
  • Cardiometabolic and renal risk
  • Collaboration with hepatology, cardiology and primary care

Contribute

Present a case, list a trial, or add a specialized capability in this area.

Professionals

No professionals have joined from Obesity and Fatty Liver (MASLD/MASH) yet.

Founding profiles are reviewed before they appear here.

Add your profile

Institutions

No institutions are listed yet.

Institutions appear once they ask to be listed or authorize a profile.

List your institution

Upcoming education

No events are scheduled yet.

Case conferences, lectures and journal clubs on this topic will be listed here.

Propose a session

Clinical trials

No trials are listed yet.

Endocrine clinical trials at member sites are listed here with links to the official registry.

List a trial

Clinical research

No projects are listed yet.

Clinical research projects seeking sites or collaborators are published here after review.

Submit a project

Publications

No publications are linked yet.

Publications by CaliEndo contributors are added with full citations, DOI and PubMed links.

Curated clinical resources

Resources are being curated.

Each resource is selected and dated by a named reviewer before it is listed.